Printer Friendly

Browse Prothrombin topic

Articles

1-201 out of 201 article(s)
Title Author Type Date Words
China Prothrombin Complex Concentrate (PCC) Investigation Market Report, 2013-2017, 2017-2018 & 2019-2023. Sep 16, 2019 1007
Supply Of Test Strips For The Determination Of Prothrombin Time In Whole Blood And Its Corresponding Puncture Devices, For Patients In The Soria Health Area. Aug 13, 2019 139
Supply Of Test Strips For The Determination Of Prothrombin Time In Whole Blood Within The Scope Of The Primary Care Management Of Burgos (spain-burgos: Reagent Strips). Aug 7, 2019 425
2019/023956 Framework Agreement With A Single Company For The Supply Of Test Strips And Transfer Of Equipment Necessary For The Determination Of Prothrombin Time In The Treatment Of Oral Anticoagulation (tao). Jul 16, 2019 111
Framework Agreement With A Single Company For The Supply Of Test Strips And Transfer Of Equipment Necessary For The Determination Of Prothrombin Time In The Treatment Of Oral Anticoagulation (oat) For The Centers Linked To The Platform Of Health Logistics. Jul 15, 2019 149
United States : Portola Pharmaceuticals Presents New In Vitro Data Demonstrating that Four-Factor Prothrombin Complex Concentrates (4F-PCCs) Had No Direct Effect on Inhibition of Thrombin Generation by Factor Xa Inhibitors. Jul 13, 2019 675
Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries. Wang, Hui-shan; Ge, Xian-xiu; Li, Quan-peng; Nie, Jun-jie; Miao, Lin Jul 1, 2019 8019
Provision Of Prothrombin Strips For The Health Service Of The Balearic Islands. May 2, 2019 117
Reactive Strips For Self-monitoring Of Inr Determination Of Prothrombin Time In Capillary Blood, Compatible With Coaguchek Device (spain-saragossa: Reagent Strips). Apr 2, 2019 127
Genetic correlation between Prothrombin G20210A polymorphism and retinal vein occlusion risk. Zou, Yuanyuan; Zhang, Xi; Zhang, Jingyi; Ji, Xiangning; Liu, Yuqing; Zhao, Shaozhen Apr 1, 2019 4583
Supply Of Test Strips For Determination Of Prothrombin Time In Whole Blood In The Field Of Primary Care Management Of Burgos. Mar 6, 2019 124
Supply Of Reagent Strips For Determination Of Prothrombin Time In Whole Blood In The Area Of the Primary Care Management Of Burgos. Mar 6, 2019 134
Supply Of Test Strips For Determination Of Prothrombin Time In Whole Blood In The Field Of Primary Care Management Of Burgos. Mar 5, 2019 122
Revisiting long-term prognostic factors of biliary atresia: A 20-year experience with 81 patients from a single center. Hanalioglu, Damla; Ozen, Hasan; Karhan, Asuman; Gumus, Ersin; Demir, Hulya; Saltik-Temizel, Inci N.; Mar 1, 2019 5907
Hematological changes in postmenopausal women. Kulkarni, Madhavi; Hiremath, Shaktiprasad Mar 1, 2019 1137
Prothrombin Time, 10 X 6 Ml. Feb 15, 2019 122
Reversal Agents for Oral Anticoagulant Rivaroxaban. Fattah, Tanzeela Abdul; Saeed, Aamer; Larik, Fayaz Ali; Channar, Pervaiz Ali Technical report Oct 31, 2018 6091
Some of the players in the Prothrombin complex concentrate market are CSL Behring, China Biologic Pr. Oct 25, 2018 260
Framework Contract For Purchase And Delivery Of Immunoglobulins And Prothrombin Complex Concentrate. Oct 11, 2018 103
Framework Contract For Purchase And Delivery Of Immunoglobulins And Prothrombin Complex Concentrate. Sep 20, 2018 101
Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population. Elkhalifa, Ahmed M. Sep 1, 2018 2700
Supply Of Reagent Strips For Determination Of Prothrombin Time In Whole Blood And Their Corresponding Puncture Devices, Intended For Patients In The Health Area Of bierzo. Aug 4, 2018 137
The bleeding edge. Mankahla, Ncedile; Lekoloane, Reneiloe; Fieggen, Graham Letter to the editor Aug 1, 2018 908
Preliminary Analysis of Factors Associated with Blood Loss in Neuromuscular Scoliosis Surgery. Toombs, Courtney; Verma, Kushagra; Lonner, Baron S.; Feldman, David; Errico, Thomas Report Jul 1, 2018 6097
Reactive Strip For The Determination Of Prothrombin Time In Blood, In Patients With Oral Anticoagulant Treatment (oat). Jun 20, 2018 123
Reactive Strip For The Determination Of Prothrombin Time In Blood, In Patients With Oral Anticoagulant Treatment (tao). Jun 18, 2018 115
Poor anticoagulation control in patients taking warfarin at a tertiary and district-level prothrombin clinic in Cape Town, South Africa. Ebrahim, I.; Bryer, A.; Cohen, K.; Mouton, J.P.; Msemburi, W.; Blockman, M. Report Jun 1, 2018 4030
Concentrate Of Activated Prothrombin Complex Agents (apcc), Parts 1 To 3, Procedure Mark: Zzp-45/18. May 15, 2018 252
Terapia secuencia!; una opcion en el paciente hemofilico que no responde a! manejo con monoterapia con agentes puente, estudio observaciona! de! GrHeCol (Grupo Hemofilia Colombia). Casas, Claudia Patricia; Sossa, Claudia Lucia; Linares, Adriana; Omana-Orduz, Olga Paola; Pena, Ange Apr 1, 2018 3705
Comparison of outcomes in patients with intracranial hemorrhage on factor Xa inhibitors versus vitamin K antagonists treated with 4-factor prothrombin complex concentrate. Harrison, Sarah K.; Garrett, John S.; Kohman, Kelsey N.; Kline, Jeffrey A. Report Apr 1, 2018 2352
Supply Of Reactive Strip For The Determination Of Prothrombin Time In Blood, In Patients With Oral Anticoagulant Treatment (oat). Mar 27, 2018 109
A comparative study on coagulation profile and neutrophil-lymphocyte ratio in pregnancy-induced hypertension. G, Swetha A; Puranik, Nagaraja; F, Kammar K Report Mar 1, 2018 4180
FREQUENCY OF PROTHROMBIN GENE MUTATION IN VENOUS THROMBOEMBOLISM IN NORTHERN PAKISTAN. Report Feb 28, 2018 2487
PROTHROMBIN G20210A GENE MUTATION IN PREGNANT FEMALES WITH THROMBOTIC OBSTETRIC COMPLICATIONS. Feb 28, 2018 2792
EFFECT OF FRESH FROZEN PLASMA TRANSFUSION ON PROTHROMBIN TIME IN PATIENTS WITH MILD COAGULATION ABNORMALITIES WHEN COMPARED WITH MAJOR COAGULATION ABNORMALITIES. Nadanganan, Sasikala; Sanshya, Mary; Dharmadas, Meena Report Feb 19, 2018 4181
Delivery Of Coagulation Factors Ii, Vii, Ix And X In Combination prothrombin Complex For The Needs Of The Federal Service For Health Care And Social Development Of The Russian Federation Ministry Of Health (chelyabinsk). Jan 21, 2018 125
Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome. Tuerdi, B.; Zuo, L.; Sun, H.; Wang, K.; Wang, Z.; Li, G. Report Jan 1, 2018 5721
The Combination of Seven Preoperative Markers for Predicting Patients with Gastric Cancer to Be Either Stage IV or Non-Stage IV. Ge, Wei; Zheng, Li-ming; Chen, Gang Jan 1, 2018 4499
Effects of 6 Months of Active Commuting and Leisure-Time Exercise on Fibrin Turnover in Sedentary Individuals with Overweight and Obesity: A Randomised Controlled Trial. Gram, Anne Sofie; Petersen, Martin Baek; Quist, Jonas Salling; Rosenkilde, Mads; Stallknecht, Bente; Jan 1, 2018 8666
Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis. Chen, Jiu; Wu, Guolin; Li, Youdi Jan 1, 2018 5893
A Surgically Treated Case of Ureterovesical Amyloidosis of the Bladder in a Patient with Idiopathic Thrombocytopenia. Kim, Sung Han; Park, Weon Seo; Joung, Jae Young; Lee, Kang Hyun; Chung, Jinsoo; Seo, Ho Kyung Jan 1, 2018 1836
Concentrate Of Activated Prothrombin Syndrome (apcc) With Delivery To The National Blood Center Deposit Warehouse. Dec 20, 2017 248
Supply Of The Complex Human Prothrombin Drug In Its Various Compositions, For All Osakidetza Service Organizations. Oct 24, 2017 165
Continuous And Continuous Supply Of Test Strips For Coagucheck Portable Prothrombin Meters, Intended For All Consorci Mar Parc De Salut Centers In Barcelona. Oct 3, 2017 103
2017-0-73 Supply Of Prothrombin Complex Drug (factor Ii, Vii, Ix, X) To The Pharmacy Service Of The University Hospital 12 De Octubre. Sep 22, 2017 156
Prolonged Prothrombin Time After Discontinuing Vitamin K Antagonist. Schellings, Mark W.M.; de Maat, Moniek P.M.; de Lathouder, Sacha; Weerkamp, Floor Clinical report Sep 1, 2017 2107
Commentary. Eby, Charles S. Sep 1, 2017 483
1prothrombin Kit 5 Ml Vial Qty: 70 Null 2blood Grp.sera Abd (3*10ml Qty: 24 Null 8null Qty: Null Null. Jul 14, 2017 117
In vitro inactivation of thrombin generation by polysulfated fractions isolated from the tropical coenocytic green seaweed Caulerpa racemosa (Caulerpaceae, Bryopsidales)/Inativacao in vitro da geracao de trombina por fracoes polissulfatadas isoladas da macroalga verde cenocitica tropical Caulerpa racemosa (Caulerpaceae; Bryopsidales). Rodrigues, Jose Arievilo Gurgel; Benevides, Norma Maria Barros; Tovar, Ana Maria Freire; Mourao, Pau Ensayo Jul 1, 2017 6646
Activated Prothrombin Complex (apcc) Concentrate; Parts: 1-2. Jun 17, 2017 198
Cardiometabolic disease and herbal medicine: new insights into an old foe. McEwen, Bradley Mar 1, 2017 333
Haemoperitoneum due to ruptured ovarian cyst in a 13-year-old girl with factor V deficiency - A case report. Feb 28, 2017 1469
Acute Unilateral Renal Infarction in the Setting of an Inherited Thrombophilia and Atrial Septal Defect. Piran, Siavash; Schulman, Sam Clinical report Jan 1, 2017 1607
Child-Pugh Parameters and Platelet Count as an Alternative to ICG Test for Assessing Liver Function for Major Hepatectomy. Au, Kin-Pan; Chan, See-Ching; Siu-Ho Chok, Kenneth; Chi-Yan Chan, Albert; Cheung, Tan-To; Kwok-Chai Report Jan 1, 2017 4187
Four-Factor Prothrombin Complex Concentrate Reduces Time to Procedure in Vitamin K Antagonist-Treated Patients Experiencing Gastrointestinal Bleeding: A Post Hoc Analysis of Two Randomized Controlled Trials. Refaai, Majed A.; Kothari, Truptesh H.; Straub, Shana; Falcon, Jacob; Sarode, Ravi; Goldstein, Joshu Report Jan 1, 2017 5622
Concentrate Activated Prothrombin Complex (apcc). Oct 26, 2016 386
Concentrate Prothrombin Complex (pcc). Oct 26, 2016 332
US FDA Clears Siemens' Xprecia Stride Coagulation Analyzer. Oct 5, 2016 186
Prothrombin Time Kit 5ml. Aug 20, 2016 330
1prothrombin Kit 3 Ml Vial Qty: 80 Null 2blood Grp.sera Abd (3*10ml Qty: 24 Null 8null Qty: Null Null. Aug 12, 2016 117
Concentrate Prothrombin Complex. Aug 5, 2016 298
A comparison study of routine coagulation screening tests (PT and APTT) by three automated coagulation analyzers. Rathod, Nitinkumar N.; Nair, Sukesh C.; Mammen, Joy; Singh, Surinder Report Aug 1, 2016 2299
Provision Of Concentrate Activated Prothrombin Complex. Jul 28, 2016 303
Concentrate Prothrombin Complex. Jul 27, 2016 296
Provision Of Concentrate Activated Prothrombin Complex. Jul 27, 2016 301
Prothrombin Time Kit 5ml. Jul 23, 2016 330
Supply Of Medical Equipment (rapid Coagulometer For Evaluating Performance Of Prothrombin Time And Inr). Jul 23, 2016 123
Medical errors and the law. Tan, S.Y. Jul 1, 2016 1358
Vitamin K associated with fewer ischemic CVD events. Jun 1, 2016 257
Tests for quantitative determination of prothrombin time in capillary blood. May 19, 2016 199
Thrombin generation assay and its application in the clinical laboratory. Tripodi, Armando Report May 1, 2016 6285
Prothrombin complex concentrate (pcc); mark case: zzp-98/16. Apr 6, 2016 292
Philippine wild medicinal mushroom, Ganoderma lucidum (Curtis: Fr.) P. Karst., exhibits anticoagulative effect in intrinsic pathway. Dulay, Rich Milton R.; De Guzman, Marwin L.; Magisa, Roselito R.; Mariano, Jenny C.; Pedro, Ma. Cris Report Apr 1, 2016 2842
Concentrate activated prothrombin complex. Mar 31, 2016 293
A study of coagulation profile in neoplastic conditions. Patel, Sarmishtha M.; Gupta, Swati; Patel, Mandakini M.; Mahadik, Juhi D.; Patel, Kinjal A.; Patel, Report Mar 1, 2016 3843
Physiological changes in some hematological and coagulation profile among Sudanese healthy pregnant women. Mohamed, Alkhansa Osama; Hamza, Khalda Mirghani; Babker, Asaad Mohammed Ahmed Report Mar 1, 2016 2737
Supply reagent for the quantitative determination of prothrombin for riojano health service. Jan 29, 2016 125
Supply of human polyvalent immunoglobulins, albumin or stable solution of plasma proteins and prothrombin complex to the members of hospilim. Jan 27, 2016 206
Thrombokinase kit of prothrombin time test isi value 1.0-1.05 liquistable. Jan 27, 2016 281
Cod. 11671 prothrombin time test reagents for measurement immediate delivery, breach acta will rise affecting him future purchases, if no accreditation in mind with no igss. Jan 19, 2016 134
Redox Nanoparticle Therapeutics for Acetaminophen-Induced Hepatotoxicity in Mice. Boonruamkaew, Phetcharat; Chonpathompikunlert, Pennapa; Nagasaki, Yukio Jan 1, 2016 5451
Comparison of modified discriminant function and Glasgow alcoholic hepatitis score in predicting one month mortality. Vasumathi, G.; Geetha, S.; Rengaraj, G. Dec 3, 2015 3179
Supply systems for the control of blood prothrombin times for primary care health centers. Dec 2, 2015 141
Clinical Applications of 4-Factor Prothrombin Complex Concentrate: A Practical Pathologist's Perspective. Unold, David; Tormey, Christopher A. Dec 1, 2015 7393
Generalidades del sistema de la coagulacion y pruebas para su estudio. Guerrero, Belsy; Lopez, Mercedes Dec 1, 2015 12773
Predictors of large esophageal varices in cirrhotic patients presenting to a tertiary care centre in south India. Anita, P.; Rahul, D.; Rao, Kondadasula Panduranga; Prabhakar, B.; Kumar, B. Ramesh; Ravikanth, K.; A Clinical report Nov 30, 2015 3448
Hematological profile in neonates--a hospital based study. Mahajan, Vidhu; Kalsotra, Nipun; Shweta; Khajuria, Arvind; Gupta, Ravinder Kumar Nov 5, 2015 3988
Supply necessary for the determination of prothrombin time (inr) by fingerstick material. Sep 28, 2015 218
Concentrate activated prothrombin factors apcc teams, the investigation sign: zzp-157/15. Sep 26, 2015 238
Assessing Clinical Laboratory Quality: A College of American Pathologists Q-Probes Study of Prothrombin Time INR Structures, Processes, and Outcomes in 98 Laboratories. Howanitz, Peter J.; Darcy, Theresa P.; Meier, Frederick A.; Bashleben, Christine P. Sep 1, 2015 6658
Point-of-care prothrombin time (pt)/international normalized ratio (inr) analyzer. Aug 26, 2015 117
(ph no.:40259) prothrombin time with calcium 10 x 4 ml. Aug 23, 2015 117
Supply of reagents for rapid determination of prothrombin time and portable reading devices (against consumption), for a period of three years. Aug 13, 2015 147
Strips for urine reagent prothrombin time and partial thromboplastin. Jul 10, 2015 113
Concentrate activated prothrombin (apcc), the investigation sign: zzp-130/15. Jul 1, 2015 259
Prothrombin time (pt) methodology: automated; use: laboratory diagnosis; reagent: yes; area: coagulation; principo: coagulometrica. May 20, 2015 106
1)prothrombin kit 3 ml vial qty: 100 null 2)blood grp.Sera abd (3*10ml) qty: 24 null 8)null qty: null null. May 15, 2015 119
Treatment of congenital bleeding, prothrombin complex concentrate in 2015 to obtain the product. May 8, 2015 142
Purchase of plasma-derived medicinal products, Albumin, Immunoglobulin and prothrombin. Apr 29, 2015 112
Drugs group b (thrombin tamp., prothrombin hum., recombinant activated factor vii and others.). Apr 8, 2015 124
Concentrate zepolu activated prothrombin factors (apcc), handling character: zzp-89/15. Apr 8, 2015 289
Vacutainer vial prothrombin 3.2 percent sodium citrate, 9nc , mfg- stanbio, bd. Feb 23, 2015 157
Supply of prothrombin time (coagulation test) rabbit thromboplastin liquid stable reagent. Feb 20, 2015 139
Supply of 1) prothrombin time (coagulation test) rabbit thromboplastin liquid stable reagent and 2)partial prothrombin time (ptt) high quality synthetic phospholipid liquid stable reagent as and when. Feb 19, 2015 163
Prothrombin time (pt) methodology: automated; use: laboratory diagnosis; reagent: yes; area: coagulation; principo: coagulometrica. Feb 11, 2015 103
Bilateral subdural hematomas, an unusual vaso-occlusive event and prolonged prothrombin time in a 58-year-old victim of an armed robbery. Anand, Kartik; Shows, Ryan; Veillon, Diana; Mills, Glenn; Munker, Reinhold Clinical report Jan 1, 2015 2418
Comparison of Anti-Xa and Dilute Russell Viper Venom Time Assays in Quantifying Drug Levels in Patients on Therapeutic Doses of Rivaroxaban. Gosselin, Robert C.; Funk, Dorothy M.; Taylor, J. Michael; Francart, Suzanne J.; Hawes, Emily M.; Fr Dec 1, 2014 3695
China Biologic Products receives approval for manufacturing of human prothrombin complex concentrate at Shandong Taibang facility. Oct 21, 2014 161
China Biologic Products receives approval for manufacturing of human prothrombin complex concentrate at Shandong Taibang facility. Oct 21, 2014 157
China Biologic to begin commercial manufacturing of human prothrombin complex concentrate at Shandong Taibang Facility. Oct 20, 2014 194
China Biologic to begin commercial manufacturing of human prothrombin complex concentrate at Shandong Taibang Facility. Oct 20, 2014 190
Concentrate teams activated prothrombin factors (apcc), proceeding character: gpp-185/14. Oct 16, 2014 187
Supply for human prothrombin pharmacy service hospital universitario de canarias. Aug 21, 2014 109
Datakit factors prothrombin concentrate. Jul 18, 2014 138
Supply of human prothrombin complex medicine in its various compositions for all service organizations osakidetza. Jul 15, 2014 148
Platelet aggregation and clotting time in type II diabetic males. Dhule, Sunita; Gawali, Swati Jul 1, 2014 1540
Supply of test strips for measuring prothrombin time for hospital centers servei de salut de les illes balears. Apr 29, 2014 125
Factor XIII: Congenital Deficiency Factor XIII, Acquired Deficiency, Factor XIII A-Subunit, and Factor XIII B-Subunit. Tahlan, Anita; Ahluwalia, Jasmina Feb 1, 2014 3364
Supply of prothrombin complex concentrate. Jan 30, 2014 209
Diagnostic performance of Des-[gamma]-carboxy prothrombin for hepatocellular carcinoma: a meta-analysis. Zhu, Rong; Yang, Jing; Xu, Ling; Dai, Weiqi; Wang, Fan; Shen, Miao; Zhang, Yan; Zhang, Huawei; Chen, Report Jan 1, 2014 6522
Evaluation of prothrombin time and activated partial thromboplastin time in hypertensive patients attending a tertiary hospital in Calabar, Nigeria. Adaeze, Nnamani Nnenna; Emeribe, Anthony Uchenna; Nasiru, Idris Abdullahi; Babayo, Adamu; Uko, Emman Report Jan 1, 2014 4408
Supply systems for the control of blood prothrombin times for health centers primary care management. Dec 13, 2013 126
Octapharma AG signs agreement with Pfizer for the Future Commercialization and Marketing in the US of human prothrombin complex concentrate. Dec 12, 2013 188
Octapharma AG signs agreement with Pfizer for the Future Commercialization and Marketing in the US of human prothrombin complex concentrate. Dec 12, 2013 184
Germany : Prothrombin Complex Concentrates Can Reverse the Anticoagulant Effects of Bayer s XareltoA. Jul 3, 2013 432
Direct thrombin inhibitors and factor Xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant. Olah, Zsolt; Szarvas, Mariann; Bereczky, Zsuzsanna; Kerenyi, Adrienne; Kappelmayer, Janos; Boda, Zol Report Jul 1, 2013 4698
Estimation of prothrombin time in pregnancy compared with normal controls. Srimala, Pannala; Khan, Inayatulla; Hari, Puli Sree Medical condition overview Jan 14, 2013 2247
Autosomal-dominant inheritance of the prothrombin gene mutation in a Puerto Rican family: a case study. Morales-Borges, Raul H. Author abstract Dec 1, 2012 1753
Utility of preoperative hematologic screening for pediatric adenotonsillectomy. Koshkareva, Yekaterina A.; Cohen, Michael; Gaughan, John P.; Callanan, Vincent; Szeremeta, Wasyl Report Aug 1, 2012 3701
Acute promyelocytic leukemia with t(15;17): a case study. Josephat, Floyd; Pruett, Erin Case study Jul 1, 2012 3023
Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome p450 enzymes by bilobalide in mice. Taki, Yuko; Yokotani, Kaori; Yamada, Shizuo; Shinozuka, Kazumasa; Kubota, Yoko; Watanabe, Yasuo; Ume Report Feb 15, 2012 5491
Cryptogenic hepatitis: a case study in autoantibody negative autoimmune hepatitis. Gacad, Vincent; Waller, Kathy Clinical report Sep 22, 2011 3215
The frequency of FV G1691A and PT G20210A mutations in an Albanian population / Arnavut populasyonunda FV G1691A ve PT G20210A mutasyonu sikligi. Atay, A. Avni; Tekin, Mustafa; Allajalebeu, Klodian; Egin, Yonca; Akar, Nejat Sep 1, 2011 1108
The protective effect of peony extract on acute myocardial infarction in rats. Mo, Xiaoyan; Zhao, Nana; Du, Xiaoyang; Bai, Liyuan; Liu, Jiankang Report Apr 15, 2011 5109
Anti-thrombosis effect of diosgenin extract from Dioscorea zingiberensis C.H. Wright in vitro and in vivo. Gong, Guohua; Qin, Yuan; Huang, Wen Report Apr 15, 2011 5446
Hemophagocytic syndrome associated with bacterial infections/ Bakteriyel enfeksiyonlarda hemofagositik sendrom. Yarali, Nese; Yildirim, Isil; Arik, Ebru; Zorlu, Pelin; Tanir, Gonul Case study Dec 1, 2010 1737
Risk assessment for clients with atrial fibrillation. Spolarich, Ann Eshenaur; Gurenlian, JoAnn R. Clinical report Dec 1, 2010 4197
Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Wang, Xin; Cheung, Ching Mei; Lee, Wayne Y.W.; Or, Penelope M.Y.; Yeung, John H.K. Report Sep 1, 2010 5841
Safety of percutaneous dilational tracheostomy in coagulopathic patients. Pandian, Vinciya; Vaswani, Ravi S.; Mirski, Marek A.; Haut, Elliott; Gupta, Shivam; Bhatti, Nasir I. Aug 1, 2010 3436
Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial. Al-Bareeq, Reem J.; Ray, A. Andrew; Nott, Linda; Pautler, Stephen E.; Razvi, Hassan Clinical report Feb 1, 2010 3025
Questions for STEP participants. Jan 1, 2010 514
Prothrombin time (Pt) and partial thromboplastin time with kaolin (Pttk) of cigarette smokers in Calabar, Cross-river State, Nigeria. Akpotuzor, J.O.; Agwunobi, L.E.; Inyama, M.A. Report Jan 1, 2009 1811
Estimation of prothombin time and activated partial thromboplastin time using the hemochron response. Weightman, W.; Sheminant, M. Sep 1, 2008 731
Third trimester itch: Obstetric Cholestasis a serious condition of pregnancy. Cronin, Robin; Maude, Robyn Clinical report Apr 1, 2008 5224
Evaluation of a prolonged prothrombin time. Hood, Joshua L.; Eby, Charles S. Apr 1, 2008 2630
Retropharyngeal hematoma as a complication of anticoagulation therapy. Akoglu, Ertap; Seyfeli, Ergun; Akoglu, Sebahat; Karazincir, Sinem; Okuyucu, Semsettin; Dagli, Ali Sa Mar 1, 2008 2131
Expanded INR monitor coverage. Anderson, Jane Brief article Feb 1, 2008 109
At last--the end of the prothrombin index. Jacobson, Barry Editorial Dec 1, 2007 249
Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease. Dieplinger, Benjamin; Lingenhel, Arno; Baumgartner, Nadja; Poelz, Werner; Dieplinger, Hans; Haltmaye Jul 1, 2007 6282
Validation of a CYP2D6 genotyping panel on the NanoChip molecular biology workstation. Lee, Hong-Kee; Lewis, Lionel D.; Tsongalis, Gregory J.; Schur, Bernard C.; Jannetto, Paul J.; Wong, May 1, 2007 4094
Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community--approved procedure and conventional external quality assessment. Poller, Leon; Keown, Michelle; Ibrahim, Saied A.; van der Meer, Felix J.M.; van den Besselaar, Anton Oct 1, 2006 3793
In the article entitled "Utility of Thrombin-Generation Assay in the Screening of Factor V G1691A (Leiden) and Prothrombin G20210A Mutations and Protein S Deficiency" by N. Hezard, L. Bouaziz-Borgi, M-G. Remy, and P. Nguyen (Clin Chem 2006;52:665-70), in Table 2 (page 668), the ETP [endogenous thrombin potential] values (as nmol/L thrombin) for persons with no thrombophilic disorder are incorrect. Correction notice Aug 1, 2006 103
Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department. Kruse, Lori; Mitchell, Alice M.; Camargo, Carlos A., Jr.; Hernandez, Jackeline; Kline, Jeffrey A. Clinical report Jun 1, 2006 4870
Prothrombin time testing practices: adherence to guidelines and standards. Shahangian, Shahram; LaBeau, Kathleen M.; Howerton, Devery A. May 1, 2006 1545
Clinical applications of whole-blood PCR with real-time instrumentation. Castley, Alison; Higgins, Melinda; Ivey, John; Mamotte, Cyril; Sayer, David C.; Christiansen, Frank Nov 1, 2005 3859
Discovering rare variants by use of melting temperature shifts seen in melting curve analysis. Lyon, Elaine Aug 1, 2005 2202
Pyrosequencing analysis of thrombosis-associated risk markers. Holmberg, Kristina; Persson, Marie-Louise; Uhlen, Mathias; Odeberg, Jacob Aug 1, 2005 1744
Atypical melting curve resulting from genetic variation in the 3' untranslated region at position 20218 in the prothrombin gene analyzed with the LightCycler factor II (prothrombin) G20210A Assay. Tag, Carmen G.; Schifflers, Marie-Claire; Mohnen, Monika; Gressner, Axel M.; Weiskirchen, Ralf Letter to the editor Aug 1, 2005 1020
Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy? Jackson, Craig M.; Esnouf, M. Peter Mar 1, 2005 2199
Acquired activated protein C resistance associated with IgG antibodies against [[beta].sub.2]-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism. Nojima, Junzo; Kuratsune, Hirohiko; Suehisa, Etsuji; Iwatani, Yoshinori; Kanakura, Yuzuru Mar 1, 2005 5459
European concerted action on anticoagulation. Quality assessment of the CoaguChek Mini and TAS PT-NC Point-of-Care whole-blood prothrombin time monitors. Poller, Leon; Keown, Michelle; Chauhan, Nikhil; van den Besselaar, Anton M.H.P.; Tripodi, Armando; S Mar 1, 2004 5185
Use of lyophilized calibrant plasmas for simplified International Normalized Ratio determination with a human tissue factor thromboplastin reagent derived from cultured human cells. van den Besselaar, Anton M.H.P.; Houdijk, Wim P.M. Dec 1, 2003 4342
Single-nucleotide polymorphism genotyping by melting analysis of dual-labeled probes: examples using factor V Leiden and prothrombin 20210A mutations. El Housni, Hakim; Heimann, Pierre; Parma, Jasmine; Vassart, Gilbert Oct 1, 2003 2226
Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Dossenbach-Glaninger, Astrid; van Trotsenburg, Michael; Dossenbach, Martin; Oberkanins, Christian; M Jul 1, 2003 4929
Exploiting the enzymatic recognition of an unnatural base pair to develop a universal genetic analysis system. Moser, Michael J.; Marshall, David J.; Grenier Jennifer K.; Kieffer, Collin D.; Killeen, Anthony A.; Mar 1, 2003 5022
The effects of Gingko biloba (egb 761) extract in combination with coumadin on haemostasis in mus musculus (the laboratory mouse). (Medical Science and Health Poster Session 09:00 AM-10:00 AM). Reeves, Hollie M. Abstract Mar 1, 2003 365
Comparison of five thrombin time reagents. Flanders, Michele M.; Crist, Ronda; Rodgers, George M. Jan 1, 2003 2205
Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room. Derhaschnig, Ulla; Laggner, Anton N.; Roggla, Martin; Hirschl, Michael M.; Kapiotis, Stylianos; Mars Nov 1, 2002 5459
European concerted action on anticoagulation. Evaluation of a method for International Sensitivity Index calibration of two point-of-care prothrombin time (PT) monitoring systems (CoaguChek Mini and TAS PT-NC) with fresh plasmas based on whole-blood equivalent PT. Poller, Leon; Keown, Michelle; Chauhan, Nikhil; van den Besselaar, Anton M.H.P.; Tripodi, Armando; S Oct 1, 2002 6109
Influence of lepirudin, argatroban, and melagatran on prothrombin time and additional effect of oral anticoagulation. Fenyvesi, Tivadar; Joerg, Ingrid; Harenberg, Job Oct 1, 2002 2787
European concerted action on anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors. Poller, Leon; Keown, Michelle; Chauhan, Nikhil; van den Besselaar, Anton M.H.P.; Meeuwisse-Braun, Jo Feb 1, 2002 3952
Determination of coumarin-type anticoagulants in human plasma by HPLC-electrospray ionization tandem mass spectrometry with an ion trap detector. Kollroser, Manfred; Schober, Caroline Jan 1, 2002 3665
Multisite study for genotyping of the factor II (prothrombin) G20210a mutation by the invader assay. Hessner, Martin J.; Friedman, Kenneth D.; Voelkerding, Karl V.; Huber, Suzanne; Ryan, Daniel; Nuccie Nov 1, 2001 2050
Laboratory investigation of thrombophilia. Tripodi, Armando; Mannucci, Pier Mannuccio Sep 1, 2001 8513
Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Fortunato, Giuliana; Castaldo, Giuseppe; Oriani, Giovannangelo; Cerini, Raimondo; Intrieri, Mariano; Sep 1, 2001 3023
EDTA samples are stable for prothrombin time measurement by combined thromboplastin reagent. Horsti, Juha Sep 1, 2001 1764
Discontinuation of the bleeding time test without detectable adverse clinical impact. Lehman, Christopher M.; Blaylock, Robert C.; Alexander, Donald P.; Rodgers, George M. Clinical report Jul 1, 2001 5676
Association between the prevalence of antibodies to [[beta].sub.2]-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Nojima, Junzo; Kuratsune, Hirohiko; Suehisa, Etsuji; Futsukaichi, Yoshiaki; Yamanishi, Hachiro; Mach Jun 1, 2001 5372
Point-of-care coagulation testing: stepping gently forward. Laposata, Michael May 1, 2001 1781
C677T and AI298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Hanson, Naomi Q.; Aras, Omer; Yang, Feng; Tsai, Michael Y. Apr 1, 2001 4323
Multiplexed mutagenically separated PCR: simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C677T) variants. Endler, Georg; Kyrle, Paul A.; Eichinger, Sabine; Exner, Markus; Mannhalter, Christine Feb 1, 2001 2232
Combined Factor V Leiden and Prothrombin Genotyping in Patients Presenting With Thromboembolic Episodes. Friedline, John A.; Ahmad, Ejaz; Garcia, Diana; Blue, Deborah; Ceniza, Noel; Mattson, Joan C.; Crisa Jan 1, 2001 5137
A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Karpati, Levente; Penke, Botond; Katona, Eva; Balogh, Istvan; Vamosi, Gyorgy; Muszbek, Laszlo Dec 1, 2000 6396
Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Dufour, D. Robert; Lott, John A.; Nolte, Frederick S.; Gretch, David R.; Koff, Raymond S.; Seeff, Le Report Dec 1, 2000 16262
Measurement of prothrombin time in EDTA plasma with combined thromboplastin reagent. Horsti, Juha Nov 1, 2000 1922
Rapid single-tube genotyping of the factor V Leiden and prothrombin mutations by real-time PCR using dual-color detection. van den Bergh, Frank A.J.T.M.; van Oeveren-Dybicz, Arletta M.; Bon, Michelle A.M. Aug 1, 2000 2736
A high factor II/factor X functional ratio is not a useful predictor of the FII G20210A gene mutation in thromboembolic patients undergoing oral anticoagulant treatment. Ordonez, Angel Jose Gonzalez; Carreira, Jose Manuel Fernandez; Alvarez, Maria Victoria; Sanchez, Leo Letter to the editor Jun 1, 2000 1174
Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting. Nichols, James H.; Kickler, Thomas S.; Dyer, Karen L.; Humbertson, Sandra K.; Cooper, Peg C.; Maugha Apr 1, 2000 4978
More on calcium ion activity buffers for coagulation testing. Koepke, John A. Letter to the editor Sep 1, 1999 715
Isocitrate as calcium ion activity buffer in coagulation assays. Ranby, Mats; Gojceta, Tony; Gustafsson, Kerstin; Hansson, Kenny M.; Lindahl, Tomas L. Aug 1, 1999 2772
Thrombophilic Mutations, OCs A Dangerous Mix. Zoler, Mitchel L. May 15, 1999 291
Rapid detection of prothrombotic mutations of prothrombin (G20210A), factor V (G1691A), and methylenetetrahydrofolate reductase (C677T) by real-time fluorescence PCR with the LightCycler. von Ahsen, Nicolas; Schutz, Ekkehard; Armstrong, Victor William; Oellerich, Michael May 1, 1999 1733
The international normalized ratio during concurrent warfarin and argatroban anticoagulation: differential contributions of each agent and effects of the choice of thromboplastin used. Hursting, Marcie J.; Zehnder, James L.; Joffrion, James L.; Becker, Jean-Claude; Knappenberger, Gary Mar 1, 1999 1888
The mutation [G.sub.20210] [right arrow] A in the prothrombin gene is a strong risk factor for pulmonary embolism. Reuner, Karl Heinrich; Ruf, Andreas; Litfin, Frank; Patscheke, Heinrich Letter to the editor Jun 1, 1998 1178
Reliable genotyping of the G-20210-A mutation of coagulation factor 11 (prothrombin). Danneberg, Jan; Abbes, Andre P.; Bruyeman, Ben J.M.; Engel, Henk; Gerrits, Jan; Martens, Alexander Feb 1, 1998 1481
Biological variation of international normalized ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Kjeldsen, Jens; Lassen, Jens Flensted; Petersen, Per Hyltoft; Brandslund, Ivan Clinical report Nov 1, 1997 4138
Factor V Leiden and other coagulation factor mutations affecting thrombotic risk. Bertina, Rogier M. Sep 1, 1997 4698
ProC[R] global: the first functional screening assay for the complete protein C pathway. Dati, Francesco; Hafner, Gerd; Erbes, Hilde; Prellwitz, Winfried; Kraus, Michael; Niemann, Frank; No Sep 1, 1997 2715
Factor X values as a means to assess the extent of oral anticoagulation in patients receiving antithrombin drugs. Hoppensteadt, Debra A.; Kahn, Steven; Fareed, Jawed Sep 1, 1997 897
Effect of Hemopure[R] on prothrombin time and activated partial thromboplastin time on seven coagulation analyzers. Moreira, Paulo L.; Lansden, Cara C.; Clark, Terri L.; Gawryl, Maria S. Sep 1, 1997 692
Suspected trimethoprim/sulfamethoxazole-induced hypoprothrombinemia. Cook, Donna E.; Ponte, Charles D. Dec 1, 1994 1789

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters